← Back to Search

Dietary Supplement

Transfer factor from colostrum ultrafiltrate for Immune Surveillance

N/A

Recruiting

Research Sponsored by Natural Immune Systems Inc

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 hours

Awards & highlights

Study Summary

This trial tests the effects of a new supplement on the immune system. The study involves 24 people who will take the supplement or a placebo at different times. Blood tests will be done to see how the supplement affects immunity.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Immune communication

Secondary outcome measures

Immune Surveillance and Alertness

Other outcome measures

Immune responsiveness

Trial Design

2Treatment groups

Experimental Treatment

Group I: Group BExperimental Treatment1 Intervention

Crossover study: Participants will be consuming the active intervention on a clinic day at least 1 week prior to a clinic day where he/she will consume placebo.

Group II: Group AExperimental Treatment1 Intervention

Crossover study: Participants will be consuming placebo on a clinic day at least 1 week prior to a clinic day where he/she will consume the active intervention.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Natural Immune Systems IncLead Sponsor

18 Previous Clinical Trials

463 Total Patients Enrolled

2 Trials studying Immune Surveillance

54 Patients Enrolled for Immune Surveillance

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the eligibility requirements for joining this research project?

"Candidates must possess a general immune health and be in the 18-75 age bracket to qualify for this medical trail. Around 24 participants are being sought after by researchers."

Answered by AI

Does this research endeavor accept participants over the age of 40?

"The lower age limit for this clinical trial is 18, with an upper bound of 75 years old."

Answered by AI

What is the participant enrollment quota for this experiment?

"Confirmed. Data hosted on clinicaltrials.gov suggests that this experiment, which was initially published on May 7th 2022 is presently enrolling candidates. It requires 24 participants recruited from 1 medical site."

Answered by AI

Is this research study currently seeking eligible participants?

"Absolutely. According to the data stored on clinicaltrials.gov, this investigation is actively recruiting participants and was initially posted on May 7th 2022. It seeks 24 volunteers from a single medical centre and its most recent update occurred on May 11th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Clinical Proof-of-concept Study on Rapid Immune Modulating Effects

2022. "Clinical Proof-of-concept Study on Rapid Immune Modulating Effects". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05364710.